"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
Vumon Patient Information including How Should I Take
In this Article
- What is teniposide (Vumon)?
- What are the possible side effects of teniposide (Vumon)?
- What is the most important information I should know about teniposide (Vumon)?
- What should I discuss with my healthcare provider before receiving this drug (Vumon)?
- How should I use teniposide (Vumon)?
- What happens if I miss a dose (Vumon)?
- What happens if I overdose (Vumon)?
- What should I avoid while receiving teniposide (Vumon)?
- What other drugs will affect teniposide (Vumon)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving this drug (Vumon)?
You should not receive this medication if you are allergic to teniposide or to a medication ingredient called Cremophor (synthetic castor oil).
To make sure you can safely receive teniposide, tell your doctor if you have any of these other conditions:
- Down Syndrome;
- bone marrow suppression;
- liver or kidney disease;
- low albumin levels; or
- a weak immune system (from disease or from taking certain medicines).
FDA pregnancy category D. Do not receive teniposide if you are pregnant. It could harm the unborn baby. Use birth control to prevent pregnancy while you are receiving teniposide, whether you are a man or a woman. Teniposide use by either parent may cause birth defects.
This medication can decrease sperm count and may affect fertility in men (your ability to have children).
It is not known whether teniposide passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using teniposide.
Using teniposide may increase your risk of developing other types of leukemia. Talk with your doctor about your specific risk.
How should I use teniposide (Vumon)?
Teniposide is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. The medicine is sometimes given slowly through an IV infusion, and can take up to 60 minutes to complete.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when teniposide is injected.
This medicine can be dangerous if it gets in your eyes, mouth, or nose, or on your skin. If this occurs, wash your skin with soap and water or rinse your eyes with water right away.
You will be watched closely for at least 60 minutes after the start of your teniposide infusion, to make sure you do not have an allergic reaction to the medication.
Teniposide can lower blood cells that help your body fight infections. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Visit your doctor regularly.
Additional Vumon Information
- Vumon Drug Interactions Center: teniposide iv
- Vumon Side Effects Center
- Vumon Overview including Precautions
- Vumon FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.